Oxaliplatin Injection, Solution
Product Images NDC 55150-331

8 FDA label images from Eugia Us Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Oxaliplatin (NDC 55150-331). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-1 (Oxaliplatin Fig1)

Figure-1 (Oxaliplatin Fig1)
A Kaplan-Meier survival curve graph showing Disease-Free Survival (DFS) probability over time in months up to 72 months. Two treatment arms are compared: FOLFOX4 (solid line) and LV5FU2 (dashed line), with the number of events and patients at risk indicated below the time axis. The graph includes hazard ratio data and p-value from a stratified log-rank test, illustrating DFS differences between the two arms.*
FDA Label Image

Figure 2 (DFS Kaplan-Meier curves by treatment arm (cutoff: 1 June 2006) – ITT population)

Figure 2 (DFS Kaplan-Meier curves by treatment arm (cutoff: 1 June 2006) – ITT population)
A Kaplan-Meier survival curve chart depicting Disease-Free Survival (DFS) probability over 72 months for Stage III patients. The chart compares two treatment arms: FOLFOX4 (solid line) and LV5FU2 (dashed line), showing DFS probability decreases over time. Hazard ratio and p-value for the logrank test are also displayed.*
FDA Label Image

Figure 3 (DFS Kaplan-Meier curves by treatment arm in Stage III patients (cutoff: 1 June 2006) – ITT population)

Figure 3 (DFS Kaplan-Meier curves by treatment arm in Stage III patients (cutoff: 1 June 2006) – ITT population)
A survival curve graph depicting the percentage of patients surviving over 24 months for three treatment groups: Oxaliplatin with 5-FU/LV, Oxaliplatin with Irinotecan, and Irinotecan with 5-FU/LV. The graph includes median survival times for each group, indicating statistical significance with P<0.0001.*
FDA Label Image

Figure 4 – Kaplan-meier Overall Survival By Treatment Arm (Oxaliplatin Fig4)

Figure 4 – Kaplan-meier Overall Survival By Treatment Arm (Oxaliplatin Fig4)
Label for Oxaliplatin Injection, USP 50 mg per 10 mL (5 mg/mL) intravenous solution. The vial is single-dose, cytotoxic agent, sterile and preservative-free. Manufactured for Eugia US LLC by AuroMedics Pharma LLC in India. Instructions include storage conditions and warnings against mixing with sodium chloride solutions. The label includes NDC 55150-331-01 and a barcode.*
FDA Label Image

Package Label-principal Display Panel-50 mg Per 10 mL (5 mg/ml) (Container Label)

Package Label-principal Display Panel-50 mg Per 10 mL (5 mg/ml) (Container Label)
Packaging label for Oxaliplatin Injection, USP 50 mg per 10 mL (5 mg/mL) sterile aqueous solution for intravenous use only. The label shows it is a single-dose vial, preservative-free, cytotoxic agent, and should not be mixed with sodium chloride or chloride-containing solutions. Distributed by AuroMedics Pharma LLC and made in India.*
FDA Label Image

Package Label-principal Display Panel-50 mg Per 10 mL (5 mg/ml) (Container-Carton (1 Vial))

Package Label-principal Display Panel-50 mg Per 10 mL (5 mg/ml) (Container-Carton (1 Vial))
Label for Oxaliplatin Injection, USP 100 mg per 20 mL (5 mg/mL) sterile aqueous solution for intravenous use. The product is indicated as a cytotoxic agent and supplied as a single-dose vial. Label states handling cautions and storage instructions. Manufactured for AuroMedics Pharma LLC by Eugia US LLC.*
FDA Label Image

Package Label-principal Display Panel-100 mg Per 20 mL (5 mg/ml) (Container Label)

Package Label-principal Display Panel-100 mg Per 20 mL (5 mg/ml) (Container Label)
Packaging label for Oxaliplatin Injection, USP, 100 mg per 20 mL (5 mg/mL) intravenous solution by Auromedics. Single-dose vial, sterile aqueous solution, preservative free. Label includes storage instructions, cytotoxic agent warning, and distributor info (AuroMedics Pharma LLC, New Jersey). Barcode and NDC 55150-332-01 visible.*
FDA Label Image

Chemical Structure (Oxaliplatin Str)

Chemical Structure (Oxaliplatin Str)
Chemical structure of oxaliplatin showing platinum coordinated with amine groups and a bidentate oxalate ligand.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.